Abdullahi Bello Umar

In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line

Sagiru Hamza Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa et al. · Bulletin of the National Research Centre/Bulletin of the National Research Center · 2022 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design of potential anti-melanoma agents against SK-MEL-5 cell line using QSAR modeling and molecular docking methods

Abdullahi Bello Umar, Adamu Uzairu, Gideon Adamu Shallangwa et al. · SN Applied Sciences · 2020 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies

Sagiru Hamza Abdullahi, Abu Tayab Moin, Adamu Uzairu et al. · Intelligent Pharmacy · 2023 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents

Sagiru Hamza Abdullahi, Adamu Uzairu, Muhammad Tukur Ibrahim et al. · Bulletin of the National Research Centre/Bulletin of the National Research Center · 2021 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2

Abdullahi Bello Umar, Adamu Uzairu, Gideon Adamu Shallangwa et al. · Heliyon · 2020 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16